These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37152016)

  • 1. Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma.
    Váncza L; Karászi K; Péterfia B; Turiák L; Dezső K; Sebestyén A; Reszegi A; Petővári G; Kiss A; Schaff Z; Baghy K; Kovalszky I
    Front Oncol; 2023; 13():1203745. PubMed ID: 37152016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPOCK1 Promotes the Development of Hepatocellular Carcinoma.
    Váncza L; Karászi K; Péterfia B; Turiák L; Dezső K; Sebestyén A; Reszegi A; Petővári G; Kiss A; Schaff Z; Baghy K; Kovalszky I
    Front Oncol; 2022; 12():819883. PubMed ID: 35186754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
    Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
    Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1.
    Li P; Xiao Z; Luo J; Zhang Y; Lin L
    J Cell Mol Med; 2019 Apr; 23(4):2475-2488. PubMed ID: 30710422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition.
    Lin YW; Wen YC; Hsiao CH; Lai FR; Yang SF; Yang YC; Ho KH; Hsieh FK; Hsiao M; Lee WJ; Chien MH
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma.
    Song X; Han P; Liu J; Wang Y; Li D; He J; Gong J; Li M; Tu W; Yan W; Liu M; Huang H; Tian D; Liao J
    J Mol Histol; 2015 Oct; 46(4-5):347-56. PubMed ID: 26077618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway.
    Du Z; Lin Z; Wang Z; Liu D; Tian D; Xia L
    Lab Invest; 2020 Aug; 100(8):1042-1056. PubMed ID: 32291390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA.
    Yao J; Hua X; Shi J; Hu X; Lui K; He K; Mai J; Lan T; Lu M
    FASEB J; 2022 Apr; 36(4):e22238. PubMed ID: 35224785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
    Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
    Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Hu X; Bao M; Huang J; Zhou L; Zheng S
    Front Oncol; 2020; 10():617539. PubMed ID: 33330112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
    Ma LJ; Wu WJ; Wang YH; Wu TF; Liang PI; Chang IW; He HL; Li CF
    J Cancer; 2016; 7(4):467-76. PubMed ID: 26918061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition.
    Chen D; Zhou H; Liu G; Zhao Y; Cao G; Liu Q
    J Cell Mol Med; 2018 Feb; 22(2):797-807. PubMed ID: 28940639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPOCK1 promotes tumor growth and metastasis in human prostate cancer.
    Chen Q; Yao YT; Xu H; Chen YB; Gu M; Cai ZK; Wang Z
    Drug Des Devel Ther; 2016; 10():2311-21. PubMed ID: 27486308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
    Front Oncol; 2023; 13():1134139. PubMed ID: 37025598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOCK1 promotes the growth of Osteosarcoma cells through mTOR-S6K signaling pathway.
    Wang Y; Wang W; Qiu E
    Biomed Pharmacother; 2017 Nov; 95():564-570. PubMed ID: 28869894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
    Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
    Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
    Fan LC; Jeng YM; Lu YT; Lien HC
    PLoS One; 2016; 11(9):e0162933. PubMed ID: 27626636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.